Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca enters into agreement with ProStrakan for rights to Moventig in Europe
-
AstraZeneca enters licensing agreement with China Medical System Holdings for hypertension medicine
-
AstraZeneca reports top-line result of tremelimumab monotherapy trial in mesothelioma
-
Acalabrutinib recommended for orphan drug designation in Europe for three indications
-
Zurampic (lesinurad) approved in the European Union for patients with gout
-
Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack
-
Durvalumab granted Breakthrough Therapy designation by US FDA for treatment of patients with PD-L1 positive urothelial bladder cancer
-
AstraZeneca and MedImmune enter consortium to deliver new treatments for chronic kidney disease
-
Full-Year and Q4 2015 Results
-
TAGRISSO™ (osimertinib) approved in EU as first-in-class treatment for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
